Leishmanasis mucocutánea tratada con miltefosine
نویسندگان
چکیده
منابع مشابه
notas clínicas0 intravenous lipoma and pulmonary sarcoidosis treated with prednisone Lipoma intravenoso y sarcoidosis pulmonar tratada con prednisona
Corticosteroid-induced lipomatosis is not a rare condition, but lipoma in the central veins has scarcely been described. According to the databases consulted, this is the first report of a lipoma within the central veins coexistent with long-term use of corticosteroid. It involved a 47-year-old male under treatment for pulmonary sarcoidosis with prednisone. Computerized tomography of the thorax...
متن کاملExtramammary Paget Disease Treated With 5% Imiquimod Cream Enfermedad de Paget extramamaria tratada con imiquimod 5% crema
observed in scalp discoid lupus erythematosus. Arch Dermatol. 2009;145:1406--9. 4. Uysal AC, Alagöz MS, Unlü RE, Sensöz O. Hairdresser’s syndrome: a case report of an interdigital pilonidal sinus and review of the literature. Dermatol Surg. 2003;29:288--90. 5. Morrell JF. ‘‘Pilonidal’’ sinus of the sole. Arch Dermatol. 1957;75:269. 6. Sakai R, Higashi K, Otha M, Sugimoto Y, Ikoma Y, Horiguchi Y...
متن کاملOral miltefosine for Indian visceral leishmaniasis.
BACKGROUND There are 500,000 cases per year of visceral leishmaniasis, which occurs primarily in the Indian subcontinent. Almost all untreated patients die, and all the effective agents have been parenteral. Miltefosine is an oral agent that has been shown in small numbers of patients to have a favorable therapeutic index for Indian visceral leishmaniasis. We performed a clinical trial in India...
متن کاملTreatment of Bolivian mucosal leishmaniasis with miltefosine.
BACKGROUND Although mucosal leishmaniasis is a prominent disease, it has been studied only to a limited extent. It is classically treated with parenteral antimony or, as a last resort, amphotericin B. METHODS We treated Bolivian mucosal leishmaniasis due to Leishmania braziliensis with the oral agent miltefosine, 2.5 mg/kg/day for 28 days, and followed-up for 12 months. RESULTS Seventy-two ...
متن کاملMiltefosine for new world cutaneous leishmaniasis.
The oral agent miltefosine has demonstrated a >95% cure rate in Indian visceral leishmaniasis. We performed a large, placebo-controlled study of miltefosine therapy (2.5 mg/kg per day orally for 28 days) against cutaneous leishmaniasis in Colombia and Guatemala. In regions in Colombia where Leishmania vianna panamensis is common, the per-protocol cure rates for miltefosine and placebo were 91% ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Médica Costarricense
سال: 2020
ISSN: 2215-5856,0001-6012
DOI: 10.51481/amc.v58i2.924